This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The new Revision Committee of the U. S. Pharmacopeia has already begun to consider recommendations on scope. A number of important policies were adopted at the 1940 U. S. Pharmacopeial Convention which apparently will be reflected in the type of articles to be included or deleted from the next revision. Because of the importance of the Pharmacopeia to the practice of medicine, the U. S. P. Subcommittee on Scope has wisely prepared a preliminary statement of the suggested changes. Both physicians and pharmacists should consider the proposals, and discussions may well be presented in the pharmaceutic and medical press. The president of the Pharmacopeial Convention and the chairman of the Subcommittee on Scope have outlined the policy under which medicinal substances have been admitted to the Pharmacopeia:
The Subcommittee on Scope, which decides admissions and deletions for a new Pharmacopeia, is primarily responsible for the value and usefulness of the
PROPOSED ADDITIONS TO AND DELETIONS FROM THE NEXT UNITED STATES PHARMACOPEIA. JAMA. 1940;115(24):2087-2088. doi:10.1001/jama.1940.02810500055018